AI Analysis AI Analysis of AKBA
Powered by GPT-4o
New!
Stock Analysis PRO
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Akebia Therapeutics stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session
(Updated on Jun 20, 2025)

Buy or Hold candidate since Apr 22, 2025 Gain 71.96%

The Akebia Therapeutics stock price gained 3.37% on the last trading day (Friday, 20th Jun 2025), rising from $3.56 to $3.68. During the last trading day the stock fluctuated 4.69% from a day low at $3.52 to a day high of $3.69. The price has risen in 6 of the last 10 days but is still down by -0.27% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $34.28 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 99.66% during the next 3 months and, with a 90% probability hold a price between $6.40 and $8.55 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock . Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)
IBKR Logo

AKBA Signals & Forecast

The Akebia Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.59 and $3.04. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, June 06, 2025, and so far it has fallen -7.30%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Akebia Therapeutics stock

Akebia Therapeutics finds support from accumulated volume at $3.64 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.165 between high and low, or 4.69%. For the last week, the stock has had daily average volatility of 4.37%.

Our recommended stop-loss: $3.49 (-5.29%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (AKBA) For The Upcoming Trading Day Of Monday 23rd

For the upcoming trading day on Monday, 23rd we expect Akebia Therapeutics to open at $3.63, and during the day (based on 14 day Average True Range), to move between $3.47 and $3.89, which gives a possible trading interval of +/-$0.206 (+/-5.59%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 11.18% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.64 (1.09%) than the resistance at $3.83 (4.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Akebia Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Akebia Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 3.646 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2025 - $3.63 ( 1.40%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*

AKBA Performance

Trading levels for AKBA

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.79 3.08%
R2 3.73 1.37%
R1 3.69 0.309%
Price 3.68
S1 3.57 -3.12%
S2 3.53 -4.17%
S3 3.46 -5.89%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.97 7.88%
R2 3.92 6.52%
R1 3.83 4.08%
Price 3.68
S1 3.64 -1.09%
S2 3.56 -3.26%
S3 2.92 -20.65%

FAQ

What is the symbol for Akebia Therapeutics Stock and on which exchange is it traded?
The symbol for Akebia Therapeutics is AKBA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akebia Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Akebia Therapeutics stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Akebia Therapeutics Stock?
Akebia Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akebia Therapeutics Stock.

What's the current price of Akebia Therapeutics Stock?
As of the end of day on the Jun 20, 2025, the price of an Akebia Therapeutics (AKBA) share was $3.68.

What is the 52-week high and low for Akebia Therapeutics Stock?
The 52-week high for Akebia Therapeutics Stock is $4.05 and the 52-week low is $0.80.

What is the market capitalization of Akebia Therapeutics Stock?
As of the Jun 20, 2025, the market capitalization of Akebia Therapeutics is 934.984M.

When is the next earnings date for Akebia Therapeutics?
The upcoming earnings date for Akebia Therapeutics is Aug 06, 2025.
Click to get the best stock tips daily for free!
ABOUT AKEBIA THERAPEUTICS
Akebia Therapeutics
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra...
GOLDEN STAR
Ticker Change Signal Date
G
GTM
$9.57
1.78% Jun 02
TAC
$8.90
27.87% May 12
UAA
$5.84
5.65% May 09
MEDP
$300.81
0.625% May 08
P
PENG
$17.23
14.80% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE